Rare and complicated, amyloidosis is defined by the buildup of amyloid proteins in cells, tissues, and organs. In amyloidosis, usually soluble amyloid proteins misfold and clump to produce insoluble fibrils that can accumulate in different areas of the body. This accumulation of amyloid fibrils can alter normal tissue structure and function, resulting to a wide range of symptoms and potentially causing organ damage.
• Different forms of amyloidosis are linked to the accumulation of different proteins. Amyloidosis comes in a variety of forms, including:
• Primary amyloidosis (also known as AL amyloidosis) is characterized by the buildup of aberrant immunoglobulin light chains (amyloidogenic light chains) and is frequently linked to diseases of the plasma cells, such as multiple myeloma.
• The amyloid A protein, an acute-phase reactant created in response to persistent inflammation or infection, has been related to the development of this form of secondary amyloidosis.
• Amyloidosis of transthyretin (ATTR) occurs when transthyretin (TTR) protein misfolds and accumulates in the body. ATTR amyloidosis can be either inherited (familial) or acquired (wild-type).
• Amyloid-beta (A) amyloidosis is most commonly linked to Alzheimer's disease due to the accumulation of amyloid-beta (A) protein in the brain.
• Individuals with ESRD who have been on dialysis for an extended period of time can develop amyloidosis. The protein beta-2 macroglobulin tends to build up in this condition.
Depending on the nature and location of the amyloid deposits, the specific symptoms and organ involvement in amyloidosis can vary. Common symptoms may include weariness, weight loss, edema (swelling), organ malfunction, and neuropathy (nerve damage). Management techniques for amyloidosis may include chemotherapy, organ transplantation, or drugs that target the underlying illness processes, and diagnosis is often a team effort.
As a group of disorders, amyloidosis spans a wide spectrum of conditions, each of which requires a unique approach to diagnosis, treatment, and care.
"synopsis" may belong to another edition of this title.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition. Seller Inventory # 47264727
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 47264727-n
Seller: California Books, Miami, FL, U.S.A.
Condition: New. Print on Demand. Seller Inventory # I-9798876695932
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Paperback. Condition: New. Seller Inventory # LU-9798876695932
Quantity: Over 20 available
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9798876695932
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9798876695932
Quantity: Over 20 available
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In. Seller Inventory # ria9798876695932_new
Quantity: Over 20 available
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New. Seller Inventory # 47264727-n
Quantity: Over 20 available
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition. Seller Inventory # 47264727
Quantity: Over 20 available
Seller: CitiRetail, Stevenage, United Kingdom
Paperback. Condition: new. Paperback. Rare and complicated, amyloidosis is defined by the buildup of amyloid proteins in cells, tissues, and organs. In amyloidosis, usually soluble amyloid proteins misfold and clump to produce insoluble fibrils that can accumulate in different areas of the body. This accumulation of amyloid fibrils can alter normal tissue structure and function, resulting to a wide range of symptoms and potentially causing organ damage.- Different forms of amyloidosis are linked to the accumulation of different proteins. Amyloidosis comes in a variety of forms, including: - Primary amyloidosis (also known as AL amyloidosis) is characterized by the buildup of aberrant immunoglobulin light chains (amyloidogenic light chains) and is frequently linked to diseases of the plasma cells, such as multiple myeloma.- The amyloid A protein, an acute-phase reactant created in response to persistent inflammation or infection, has been related to the development of this form of secondary amyloidosis.- Amyloidosis of transthyretin (ATTR) occurs when transthyretin (TTR) protein misfolds and accumulates in the body. ATTR amyloidosis can be either inherited (familial) or acquired (wild-type).- Amyloid-beta (A) amyloidosis is most commonly linked to Alzheimer's disease due to the accumulation of amyloid-beta (A) protein in the brain.- Individuals with ESRD who have been on dialysis for an extended period of time can develop amyloidosis. The protein beta-2 macroglobulin tends to build up in this condition.Depending on the nature and location of the amyloid deposits, the specific symptoms and organ involvement in amyloidosis can vary. Common symptoms may include weariness, weight loss, edema (swelling), organ malfunction, and neuropathy (nerve damage). Management techniques for amyloidosis may include chemotherapy, organ transplantation, or drugs that target the underlying illness processes, and diagnosis is often a team effort.As a group of disorders, amyloidosis spans a wide spectrum of conditions, each of which requires a unique approach to diagnosis, treatment, and care. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Seller Inventory # 9798876695932
Quantity: 1 available